Carlisle Companies (NYSE:CSL) announced today that it has completed its acquisition of Providien for an undisclosed amount.
San Diego-based Providien provides solutions for global medical technology OEMs, such as contract manufacturing, precision machining and metals, thermoforming and injection molding. The acquisition, which was initially announced last month, is part of Scottsdale, Ariz.-based Carlisle’s plan to drive earnings by $15 per share.
According to the initial announcement, Providien and its more than 1,000 employees will become part of the Carlisle Interconnect Technologies division for electrosurgical, imaging, interventional, surgical, patient monitoring and medical cable products. In Providien, CIT also establishes product development and manufacturing in the U.S.
Shares of CSL closed today down -2.1% at $159.40 per share but were up 0.4% at $159.99 after hours.
